Matthias Alexander Lechner

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Foundation Medicine, Inc., Ucl Business Plc. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Alexander Lechner. Retrieved from https://idiyas.com/inventor/matthias-alexander-lechner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

5 out of 47

Foundation Medicine, Inc.

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11766439 - Human papilloma virus as predictor of cancer prognosis (2023-09-26),

2. 11058687 - Human papilloma virus as predictor of cancer prognosis (2021-07-13),

3. 9907798 - Methods of treating head and neck cancer (2018-03-06),

4. 9410954 - Human papilloma virus as predictor of cancer prognosis (2016-08-09),

5. 8673972 - Human papilloma virus as predictor of cancer prognosis (2014-03-18),

Title: Matthias Alexander Lechner: Innovator in Cancer Treatment

Introduction

Matthias Alexander Lechner is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the area of head and neck cancers. With a total of 5 patents to his name, Lechner's work has the potential to impact cancer prognosis and treatment methodologies.

Latest Patents

Lechner's latest patents focus on the role of the human papilloma virus (HPV) as a predictor of cancer prognosis. His innovative methods for treating head and neck cancer are disclosed in these patents, showcasing his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Lechner has worked with notable companies such as Foundation Medicine, Inc. and UCL Business Plc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Lechner has collaborated with esteemed colleagues, including Chris Hendrik Boshoff and Timothy Robert Fenton. These partnerships have further enriched his research and development efforts in cancer treatment.

Conclusion

Matthias Alexander Lechner is a dedicated inventor whose work in cancer research is paving the way for innovative treatment options. His contributions are vital in the ongoing fight against cancer, and his patents reflect his expertise and commitment to improving patient care.

Profile summary based on public USPTO records.